Get the Stockscreener App
4.35
0.00%
0.00
Outset Medical Inc stock is traded at $4.35, with a volume of 68,035.
It is up +0.00% in the last 24 hours and up +33.64% over the past month.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
See More
Previous Close:
$4.35
Open:
$4.36
24h Volume:
68,035
Relative Volume:
0.10
Market Cap:
$79.73M
Revenue:
$119.48M
Net Income/Loss:
$-81.65M
P/E Ratio:
-0.6392
EPS:
-6.8055
Net Cash Flow:
$-47.13M
1W Performance:
+3.57%
1M Performance:
+33.64%
6M Performance:
-67.94%
1Y Performance:
-61.77%
1-Day Range:
$4.289
$4.44
1-Week Range:
$4.07
$4.45
52-Week Range:
$3.00
$21.98
Outset Medical Inc Stock (OM) Company Profile
Name
Outset Medical Inc
Sector
Industry
Phone
669-231-8200
Address
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
4.354 | 79.66M | 119.48M | -81.65M | -47.13M | -6.8055 |
ABT
Abbott Laboratories
|
102.14 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
342.71 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.59 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.56 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.32 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-21-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-08-24 | Initiated | BTIG Research | Buy |
| Apr-05-24 | Upgrade | CL King | Neutral → Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-17-23 | Initiated | CL King | Neutral |
| Nov-11-22 | Initiated | RBC Capital Mkts | Outperform |
| Jul-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-18-21 | Initiated | Cowen | Outperform |
| Apr-19-21 | Initiated | Wells Fargo | Overweight |
| Dec-16-20 | Initiated | Oppenheimer | Perform |
| Oct-12-20 | Initiated | Barclays | Overweight |
| Oct-12-20 | Initiated | BofA Securities | Buy |
| Oct-12-20 | Initiated | Goldman | Buy |
| Oct-12-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-12-20 | Initiated | SVB Leerink | Mkt Perform |
| Oct-12-20 | Initiated | Stifel | Buy |
View All
Outset Medical Inc Stock (OM) Latest News
RBC Capital Maintains Outset Medical(OM.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule - National Today
Outset Medical Reports Nasdaq Inducement Grant - National Today
Outset Medical (OM) EVP granted 96,000 restricted stock units in equity award - Stock Titan
Outset Medical (OM) EVP Elliott Derick A. files initial Form 3 insider report - Stock Titan
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Outset Medical gives new commercial chief 96,000 stock units - Stock Titan
Outset Medical, Inc. (NASDAQ:OM) Position Lowered by National Bank of Canada FI - 富途牛牛
TD Cowen Initiates Outset Medical(OM.US) With Buy Rating, Announces Target Price $12 - Moomoo
Outset Medical adds former Stryker leader as new EVP of commercial - MassDevice
Outset Medical names Derick Elliott commercial chief By Investing.com - Investing.com Canada
Outset Medical Names Derick Elliott as Executive Vice President of Commercial - National Today
Outset Medical names Derick Elliott commercial chief - Investing.com
Outset Medical, Inc. Appoints Derick Elliott as Executive Vice President of Commercial, Effective April 6, 2026 - marketscreener.com
Market Moves: Is Outset Medical Inc stock risky to hold nowTrade Performance Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
OM PE Ratio & Valuation, Is OM Overvalued - Intellectia AI
Outset Medical Gets Investor Suit Over Device Approval Trimmed - Bloomberg Law News
ETF Watch: Can Outset Medical Inc sustain earnings growthWeekly Risk Report & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Outset Medical (NASDAQ:OM) Upgraded at Wall Street Zen - MarketBeat
Vanguard realigns reporting; Outset Medical (OM) shows 0% stake - Stock Titan
Resistance Check: What is Outset Medical Incs 5 year growth outlookRecession Risk & Daily Technical Forecast Reports - baoquankhu1.vn
If You Invested $1,000 in Outset Medical, Inc. (OM) - Stock Titan
OM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
OM.O Technical Analysis & Stock Price Forecast - Intellectia AI
Outset Medical to detail in-house dialysis rollout and nurse impact at AONL2026 - Traders Union
OM SEC FilingsOutset Medical, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Why Did Outset Medical Stock Tumble Today? - MSN
Outset Medical bets on workflow efficiency gains with Tablo Dialysis during AONL2026 - tradersunion.com
Analyst sentiment on Outset Medical (OM) remains strong following Q4 results - MSN
Short Interest in Outset Medical, Inc. (NASDAQ:OM) Drops By 13.6% - MarketBeat
Momentum Shift: What is Outset Medical Incs 5 year growth outlookQuarterly Profit Summary & Safe Swing Trade Setups - baoquankhu1.vn
Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Outset Medical (OM) soars 22.2%: Is further upside left in the stock? - MSN
Outset Medical, Inc. $OM Position Lessened by Pura Vida Investments LLC - MarketBeat
Shorts Report: Is Outset Medical Inc in a bullish channelEarnings Recap Report & Real-Time Volume Surge Alerts - baoquankhu1.vn
Outset Medical (OM) insider amends Form 3 to add option holdings - Stock Titan
OM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FDA Clears Outset Medical’s Next-Generation Hemodialysis System - Medical Product Outsourcing
Outset Medical Earnings Call Highlights Margin Turnaround - TipRanks
Outset Medical webinar spotlights Community Health Systems insourced dialysis expansion - Traders Union
Analysts Are Bullish on Top Healthcare Stocks: Entrada Therapeutics Inc (TRDA), Outset Medical (OM) - The Globe and Mail
Outset Medical, Inc. (OM) Stock Analysis: A Potential 211% Upside Sparks Investor Interest - DirectorsTalk Interviews
Aug Retail: What is Outset Medical Incs 5 year growth outlookPortfolio Return Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Does Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect? - MSN
Exit Recap: Can Outset Medical Inc sustain earnings growthForecast Cut & High Yield Stock Recommendations - baoquankhu1.vn
OMOutset Medical, Inc. Latest Stock News & Market Updates - Stock Titan
Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results - Yahoo Finance
Leslie Trigg Sells 3,361 Shares of Outset Medical (NASDAQ:OM) Stock - MarketBeat
Outset Medical general counsel Brottem sells $9,520 in stock - Investing.com
Outset Medical general counsel Brottem sells $9,520 in stock By Investing.com - Investing.com UK
Outset Medical Inc Stock (OM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Outset Medical Inc Stock (OM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Trigg Leslie | Chair and CEO |
Feb 17 '26 |
Sale |
3.35 |
3,361 |
11,259 |
102,342 |
| Nash Marc | EVP Operations R&D & Service |
Feb 17 '26 |
Sale |
3.35 |
1,817 |
6,087 |
39,988 |
1.66%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):